| Joanne Payne, MS, CCC-A | |
|
608 Kirkwood Dr, Northport, AL 35473-1633 | |
| (205) 333-0942 | |
| Not Available |
| Full Name | Joanne Payne |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 608 Kirkwood Dr, Northport, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578729299 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 654A (Alabama) | Primary |
| Provider Name | Board Of Trustees, University Of Alabama |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285771261 PECOS PAC ID: 8325096605 Enrollment ID: O20050104000762 |
News Archive
Researchers from Purdue and Stony Brook universities have determined the precise atomic-scale structure of the poliovirus attached to key receptor molecules in human host cells and also have taken a vital snapshot of processes leading to infection.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
Numerous studies have shown that highly impulsive behavior - defined as the tendency to choose small, immediate rewards over larger, delayed rewards - is more prevalent in drug addicts and alcoholics compared to individuals without addictions.
Researchers from the University of Illinois at Urbana-Champaign have developed a highly sensitive biosensor based on a differential immuno-capture technology that can detect sub-populations of white blood cells. As part of a small, disposable biochip, the microfluidic biosensor can count CD4+/CD8+ T cells quickly and accurately for AIDS diagnosis in the field.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joanne Payne, MS, CCC-A 608 Kirkwood Dr, Northport, AL 35473-1633 Ph: (205) 333-0942 | Joanne Payne, MS, CCC-A 608 Kirkwood Dr, Northport, AL 35473-1633 Ph: (205) 333-0942 |
News Archive
Researchers from Purdue and Stony Brook universities have determined the precise atomic-scale structure of the poliovirus attached to key receptor molecules in human host cells and also have taken a vital snapshot of processes leading to infection.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
Numerous studies have shown that highly impulsive behavior - defined as the tendency to choose small, immediate rewards over larger, delayed rewards - is more prevalent in drug addicts and alcoholics compared to individuals without addictions.
Researchers from the University of Illinois at Urbana-Champaign have developed a highly sensitive biosensor based on a differential immuno-capture technology that can detect sub-populations of white blood cells. As part of a small, disposable biochip, the microfluidic biosensor can count CD4+/CD8+ T cells quickly and accurately for AIDS diagnosis in the field.
› Verified 2 days ago